These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 5121520)

  • 1. [Supravital staining experiments concerning the problem of metabolism in the CNS of the rat, especially in the hypothalamus and infundibulum].
    Eberhardt HG
    Z Mikrosk Anat Forsch; 1971; 83(4):525-34. PubMed ID: 5121520
    [No Abstract]   [Full Text] [Related]  

  • 2. Transport and effects of cationic dyes and tetrazolium salts in the central nervous system.
    Koenig H
    Prog Brain Res; 1968; 29():87-123. PubMed ID: 5735125
    [No Abstract]   [Full Text] [Related]  

  • 3. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Abbott NJ
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reactive changes in the central nervous system and endocrine organs in burn-irradiation lesions].
    Pilipenko NI
    Biull Eksp Biol Med; 1967 Apr; 63(4):48-52. PubMed ID: 5618128
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood-brain barrier permeability considerations for CNS-targeted compound library design.
    Hitchcock SA
    Curr Opin Chem Biol; 2008 Jun; 12(3):318-23. PubMed ID: 18435937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 1. Anti-infective drugs.
    Adenot M; Perriere N; Scherrmann JM; Lahana R
    Chemotherapy; 2007; 53(1):70-2. PubMed ID: 17202814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M
    J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symposium on membrane transport. Transport in the central nervous system.
    Davson H; Oldendorf WH
    Proc R Soc Med; 1967 Apr; 60(4):326-9. PubMed ID: 6021942
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury.
    Sharma HS; Ali SF
    Ann N Y Acad Sci; 2008 Oct; 1139():242-58. PubMed ID: 18991870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 2. Cationic peptide vectors for brain delivery.
    Adenot M; Merida P; Lahana R
    Chemotherapy; 2007; 53(1):73-6. PubMed ID: 17202815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine.
    Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 Jan; 280(1):402-9. PubMed ID: 8996221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin content in the developing rat brain in relation to the blood-brain barrier.
    Skultétyová I; Tokarev DI; Jezová D
    Endocr Regul; 1993 Dec; 27(4):209-13. PubMed ID: 8068898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.
    Summerfield SG; Read K; Begley DJ; Obradovic T; Hidalgo IJ; Coggon S; Lewis AV; Porter RA; Jeffrey P
    J Pharmacol Exp Ther; 2007 Jul; 322(1):205-13. PubMed ID: 17405866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis.
    Ross TM; Martinez PM; Renner JC; Thorne RG; Hanson LR; Frey WH
    J Neuroimmunol; 2004 Jun; 151(1-2):66-77. PubMed ID: 15145605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium fluorescein penetration from the perfused cerebral ventricles into different areas of the rat hypothalamus.
    Scremin OU
    J Physiol; 1968 Jan; 194(1):42P. PubMed ID: 5639786
    [No Abstract]   [Full Text] [Related]  

  • 16. Leptin transport in the central nervous system.
    Ziylan YZ; Baltaci AK; Mogulkoc R
    Cell Biochem Funct; 2009 Mar; 27(2):63-70. PubMed ID: 19205004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter.
    Allen DD; Lockman PR; Roder KE; Dwoskin LP; Crooks PA
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1268-74. PubMed ID: 12604705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of enantiomers of trans-tramadol and trans-O-demethyltramadol in central nervous system of rats.
    Liu HC; Wang N; Liu CS; Hu YQ; Liu JF; Hou YN
    Acta Pharmacol Sin; 2001 Oct; 22(10):871-5. PubMed ID: 11749767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of nadrolone (nortestosterone) on stress enhancement of nonesterified fatty acids in central nervous system.
    Sklenovský A; Navrátil J; Dostálová K; Chmela Z
    Homeost Health Dis; 1991; 33(5-6):296-7. PubMed ID: 18265506
    [No Abstract]   [Full Text] [Related]  

  • 20. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.